Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AmerisourceBergen Corporation
AmerisourceBergen Reports $0.73 Diluted EPS from Continuing Operations, Up 18 Percent, and Revenue Up 5 Percent in the September Quarter
November 23rd, 2008
AmerisourceBergen Corporation (NYSE:ABC) reported that in its fiscal year 2008 fourth quarter ended September 30, 2008, total revenue increased 5 percent to $17.2 billion, and diluted earnings per share from continuing operations were $0.73, an 18 percent increase over the previous fiscal year's fourth quarter. Fiscal Fourth Quarter Highlights -- Total revenue of $17.2 billion, up 5 percent. -- Diluted earnings per share from continuing operations of $0.73, up 18 percent. -- Pharmaceutical Distribution operating margin of 1.19 percent, up 17 basis points. -- Cash flow from operations of $514...
Source: Pharma Investments, Ventures & Law Weekly (2008-11-23)
|
